zoledronic acid has been researched along with Cancer of the Thyroid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, FK; Deng, ZY; Feng, ZP; Hou, F; Jia, L; Liu, C; Liu, PJ; Lv, J; Yang, ZX | 1 |
Imamura, Y; Matsuda, S; Sano, K; Umeda, Y; Yoshida, H; Yoshimura, H | 1 |
Jung, HD; Jung, YS; Kim, DW; Park, HS | 1 |
Manabe, J; Miyata, S; Orita, Y; Sugitani, I; Takao, S; Toda, K | 1 |
Gros Herguido, N; Guerrero-Vázquez, R; Martínez Brocca, MA; Moreno Reina, E; Navarro González, E | 1 |
Fujimoto, Y; Manabe, J; Orita, Y; Sugitani, I; Toda, K | 1 |
Abbruzzese, A; Borghi, MO; Caraglia, M; Castiglioni, S; Colao, A; Crinò, L; Dicitore, A; Faggiano, A; Ferolla, P; Ferone, D; Hofland, L; Ramundo, V; Severino, R; Sperlongano, P; Vitale, G | 1 |
Barutca, S; Erdogan, S; Koseoglu, K; Meydan, N; Yurekli, Y | 1 |
8 other study(ies) available for zoledronic acid and Cancer of the Thyroid
Article | Year |
---|---|
Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Topics: Animals; Antigens, CD; beta Catenin; Cadherins; Carcinogenesis; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; Humans; Macrophages; Male; Mice; Mice, Nude; Signal Transduction; THP-1 Cells; Thyroid Neoplasms; Tumor Microenvironment; Wnt Signaling Pathway; Zoledronic Acid | 2020 |
Mandibular metastasis as the first clinical indication of occult lung adenocarcinoma with multiple metastases: A case report.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Gefitinib; Humans; Imidazoles; Immunohistochemistry; Lung; Lung Neoplasms; Mandible; Mandibular Neoplasms; Neoplasm Grading; Neoplasm Staging; Quinazolines; Thyroid Neoplasms; Treatment Outcome; Zoledronic Acid | 2018 |
Osteonecrosis of the jaw related to everolimus: a case report.
Topics: Angiogenesis Inhibitors; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Everolimus; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Middle Aged; Osteonecrosis; Sirolimus; Thyroid Neoplasms; Thyroidectomy; Zoledronic Acid | 2013 |
Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.
Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Male; Middle Aged; Pain; Peptides; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Spinal Cord Compression; Thyroid Neoplasms; Zoledronic Acid | 2015 |
Advanced thyroid carcinoma in pregnancy: case report of two pregnancies.
Topics: Adenocarcinoma, Follicular; Adult; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Metastasectomy; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Spinal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Zoledronic Acid | 2015 |
Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma.
Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Osteoclasts; Thyroid Neoplasms; Treatment Outcome; Zoledronic Acid | 2011 |
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
Topics: Aged; Apoptosis; beta-Galactosidase; Blotting, Western; Calcitonin; Cell Cycle; Cell Proliferation; Cellular Senescence; Diphosphonates; Everolimus; Humans; Imidazoles; Male; Middle Aged; Sirolimus; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Zoledronic Acid | 2012 |
Reversible metastatic visceral calcification detected by 99mTc-methylene diphosphonate bone scanning in breast cancer.
Topics: Antineoplastic Agents; Bone and Bones; Breast Neoplasms; Calcification, Physiologic; Calcium; Diphosphonates; Female; Heart Neoplasms; Humans; Imidazoles; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Technetium Tc 99m Medronate; Thyroid Neoplasms; Time Factors; Zoledronic Acid | 2005 |